Browsing Category
Armor Pharma
Pediatric-friendly suspension for oral administration of pyrimethamine in congenital toxoplasmosis:…
Abstract
This study focused on developing and assessing the stability of pyrimethamine (PYM) sugar-free oral suspensions for treating congenital toxoplasmosis in the pediatric population, including neonates. Extemporaneous suspensions (2 mg/mL) were prepared using carboxymethylcellulose (CMC) or…
Read More...
Read More...
Comparison of in vitro screening methods for evaluating the effects of pharmaceutical excipients on…
The effects of pharmaceutical excipients on intestinal drug absorption have been highlighted and careful excipient selection is required to develop biologically equivalent formulations. This study aimed to evaluate the effects of excipients on drug permeability and compare the characteristics of in…
Read More...
Read More...
Relaxation tests for the time dependent behavior of pharmaceutical tablets: A revised interpretation
Relaxation tests are often used in the pharmaceutical field to assess the strain rate sensitivity of pharmaceutical powders and tablets. These tests involve applying a constant strain to the powder in the die and then monitoring the stress evolution over time. Interpreting these tests is complicated…
Read More...
Read More...
CPHI Milan 2024 – with a focus on excipients
This year CPHI Europe opens its doors in Milano at Fiera Milano.
From 8th to 10th October you can have a face-to-face chat with visitors and exhibitors again. As usual, InnoPack,
P-MEC, FDF, ICSE, MedTech and BioProduction will be held together with CPHI.
Pharma Excipients gives you an overview…
Read More...
Read More...
Redispersible dry powders containing nanoencapsulated curcumin increase its antioxidant activity
The present study aimed to develop redispersible spray-dried powders containing curcumin-loaded Eudragit® L100 nanocapsules and evaluate their physicochemical properties and antioxidant potential. The spray drying process showed a yield of over 85%, low residual moisture content (<2%), and all…
Read More...
Read More...
Development of immediate-release formulation with reliable absorption of rivaroxaban in various meal…
The bioavailability of rivaroxaban at the higher doses (15 and 20 mg) is considerably reduced when the drug is administered on an empty stomach. This can lead to inadequate anticoagulant effect, and therefore, it is recommended to use the higher doses at fed state. However, proper posology may…
Read More...
Read More...
Vitafoods Geneva 2024 – with a focus on excipients
This year Vitafoods Europe opens its doors for the last time in Geneva at Palexpo.
From 14th to 16th May you can have a face-to-face chat with visitors and exhibitors again.
Pharma Excipients gives you an overview of the excipient suppliers, their booths, main topics and products in the…
Read More...
Read More...
Effects of omitting titanium dioxide from the film coating of a pharmaceutical tablet
An industrial case study of attempting to comply with EU regulation 2022/63
Recently, concerns have been raised about the safety of titanium dioxide (TiO2), a commonly used component of pharmaceutical film coatings. The European Union has recently prohibited the application of this material in the…
Read More...
Read More...
Implementation of near-infrared spectroscopy and convolutional neural networks for predicting…
Monitoring the particle size distribution (PSD) is crucial for controlling product quality during fluidized bed granulation. This paper proposed a rapid analytical method that quantifies the D10, D50, and D90 values using a Convolutional Block Attention Module-Convolutional Neural Network (CBAM-CNN)…
Read More...
Read More...
See the Galenic Laboratory at Armor Pharma
Since 2020, Armor Pharma has invested in a state-of-the-art galenic laboratory, reinforcing their expertise as a pharmaceutical lactose supplier.
Watch the new video State-of-the-art Galenic Laboratory by Armor Pharma below:
Thanks to a partnership with MEDELPHARM, they use…
Read More...
Read More...